The Chan Lab’s work on BOLA3 and pulmonary hypertension was selected as a 2019 top research advance by the AHA in heart disease and stroke!
Read on the AHA website:
Yu Q, Tai YY, Tang Y, Zhao J, Negi V, Culley MK, Pilli J, Sun W, Brugger K, Mayr J, Saggar R, Saggar R, Wallace WD, Ross DJ, Waxman AB, Wendell SG, Mullett SJ, Sembrat J, Rojas M, Khan OF, Dahlman JE, Sugahara M, Kagiyama N, Satoh T, Zhang M, Feng N, Gorcsan J 3rd, Vargas SO, Haley KJ, Kumar R, Graham BB, Langer R, Anderson DG, Wang B, Shiva S, Bertero T, Chan SY. BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension. Circulation. 2019 May 7;139(19):2238-2255. doi: 10.1161/CIRCULATIONAHA.118.035889. PDF; PMID: 30759996; PMCID: PMC6519484.
Top heart disease and stroke research advances in 2019https://t.co/ZQP0MENIHG
— American Heart News (@HeartNews) December 31, 2019
ICYMI: The American Heart Association identifies the year’s most impactful scientific discoveries https://t.co/uoFJy42jgM pic.twitter.com/1WdWN9CQ1R
— American Heart News (@HeartNews) January 3, 2020